Physician Assistant · Sacramento, CA
NPI
1861020190
Since 2020
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3814 Auburn Blvd Ste 72
Sacramento, CA, 95821
Phone (916) 426-1902
Medicare paid, 2024
$311K
23,451 services
Medicare patients, 2024
457
Average age 76
Drug cost, 2024
$2.6M
3,706 prescriptions
Company payments, 2025
$1,304
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph F Karpel II was code J3111 (injection, romosozumab-aqqg, 1 mg), 17,010 times for 22 patients. In total Joseph F Karpel II billed 23,451 services in 15 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 17,010 | 22 | $8.47 | $144K |
| J0897 Injection, denosumab, 1 mg | Office | 5,402 | 76 | $20.09 | $109K |
| 99213 Office E&M - Established | Office | 319 | 256 | $61.49 | $20K |
| 99214 Office E&M - Established | Office | 296 | 227 | $86.18 | $26K |
| 96372 Injection Administration | Office | 179 | 95 | $10.38 | $1,857 |
| 95251 Test - Miscellaneous | Office | 108 | 82 | $24.52 | $2,648 |
| 99212 Office E&M - Established | Office | 79 | 38 | $42.70 | $3,374 |
| 95250 Test - Miscellaneous | Office | 23 | 21 | $138.89 | $3,194 |
By year: 2022 $107K for 8,057 services; 2023 $319K for 24,666 services; 2024 $311K for 23,451 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph F Karpel II prescribed most often to Medicare patients was Ozempic (Semaglutide), with 503 prescriptions and refills. In total Joseph F Karpel II wrote 3,706 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 503 | 933 | 123 | $897K |
| Levothyroxine Sodium Generic | 371 | 1,076 | 116 | $5,035 |
| Alendronate Sodium Generic | 237 | 630 | 67 | $2,940 |
| Mounjaro Tirzepatide | 211 | 318 | 42 | $335K |
| Metformin Hcl Er Metformin Hcl | 200 | 543 | 65 | $3,354 |
| Jardiance Empagliflozin | 166 | 423 | 55 | $241K |
| Synthroid Levothyroxine Sodium | 139 | 376 | 40 | $13K |
| Metformin Hcl Generic | 113 | 317 | 32 | $1,207 |
| Atorvastatin Calcium Generic | 92 | 274 | 31 | $1,055 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 78 | 227 | 35 | $6,997 |
| Trulicity Dulaglutide | 74 | 127 | 16 | $124K |
| Tymlos Abaloparatide | 62 | 74 | 13 | $199K |
| Humalog Kwikpen U-100 Insulin Lispro | 60 | 137 | 21 | $18K |
| Liothyronine Sodium Generic | 59 | 177 | 21 | $3,140 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 54 | 74 | Under 11 | $60K |
Brand drugs: 1,917 claims; generic drugs: 1,574 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph F Karpel II $1,304 ($1,304 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $210.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $210 |
| Abbott Laboratories ABT | 3 | $191 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $179 |
| Sequel Med Tech, LLC | 1 | $159 |
| Beta Bionics, Inc. BBNX | 5 | $135 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $69.2 |
| Novo Nordisk Inc NVO | 3 | $65.63 |
| Dexcom, Inc. DXCM | 2 | $51.33 |
| Tolmar, Inc. | 2 | $48.84 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $39.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.